Securities crowdfunding platform SeedInvest has closed its largest offering since platform launch. NowRX closed this past Friday and according to the offering page, NowRX raised $29,268, 351. The offering was being listed under the Reg A+ securities exemption, a vehicle that allows issuers to raise… Read More
NowRX, the largest securities crowdfunding campaign ever on SeedInvest will close within a few days. As has been previously reported, NowRX is an emerging Medtech firm that may be described as the Uber for prescriptions as it provides same-day delivery for pharmaceuticals prescribed by doctors…. Read More
NowRX, a pharmaceutical delivery service and digital health platform, has now topped $20 million on SeedInvest – making it the biggest raise on the securities crowdfunding platform to date. As has been previously reported, NowRX is offering preferred equity at a pre-money valuation of $275… Read More
NowRX, one of the largest funding rounds ever listed on SeedInvest, is scheduled to close its current Series C round on May 20, 2022, according to an email. As it stands today, NowRX has raised $18.6 million from over 6100 investors. NowRX is selling preferred… Read More
Towards the end of 2021, NowRX announced a Series C funding round on the securities crowdfunding platform SeedInvest. The Reg A+ offering was seeking preferred equity at a pre-money valuation of $275 million. Today, the offering is still live and over 5100 individual investors have… Read More
NowRX, has returned to SeedInvest for its Series C funding round. According to the offering page, NowRX is raising capital at a pre-money valuation of $275 million. The size of the round is indicative of the ability for more mature firms to raise capital online…. Read More
NowRX, a great business for the current COVID-19 infused world, raised $20 Million in Series B funding via securities listed on SeedInvest. The $20 million securities offering is the largest raise ever for SeedInvest, according to a note from NowRX. The securities are being issued… Read More
NowRX is raising growth capital on SeedInvest and it is nearing its $20 million crowdfunding goal, according to the offering page. NowRX is an on-demand pharmacy, a new entrant in the gig-economy that is perfectly positioned for the new COVID-19 reality. NowRX seeks to disrupt… Read More
NowRx, a Medtech firm for the times, has now topped $8 million on SeedInvest as almost 4000 investors have backed the Reg A+ crowdfunding round. As has been previously reported, NowRx is an on-demand pharmacy providing free delivery. Kind of like the Uber Eats of… Read More
NowRX continues to raise capital on SeedInvest. The Reg A+ offering now stands at over $5.2 million backed by more than 2500 investors. NowRX now represents one of SeedInvests largest ever crowdfunding rounds. The deal is for preferred equity at a pre-money valuation of $65… Read More
Launched last fall on SeedInvest, NowRx has recently topped $4 million. The Reg A+ offering is said to have secured the spot as “most raised live deal on SeedInvest.” Crowdfund Insider covered the NowRX crowdfunding round last October. At that time, it was reported that… Read More
NowRx, an on-demand pharmacy that provides same-day delivery, is returning to SeedInvest for its 3rd crowdfunded offering. NowRx is seeking up to $20 million on a pre-money valuation of $65 million. Like many of the offerings on SeedInvest, investors get preferred equity in the Series… Read More
LAUNCH Festival, a two-day event hosted by Jason Calacanis, kicked off yesterday with a new twist. Live crowdfunding was offered for a handful of companies that were simultaneously listed on the SeedInvest crowdfunding platform. These companies each delivered a 3 minute explanatory pitch to a… Read More
Crowdfund Insider is the leading news website covering the emerging global industry of disruptive finance including investment crowdfunding, Blockchain, online lending, and other forms of Fintech.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it and agree to our terms of service.Ok
